GoPath Diagnostics

GoPath Diagnostics is proud to announce our new national agreement with Capstone Health Alliance, bringing advanced pathology and molecular diagnostic services to hundreds of hospitals across the country. This agreement gives Capstone members direct access to GoPath's full diagnostic portfolio, including molecular oncology, hereditary genetic testing, hematopathology, and digital pathology solutions. For hospital networks looking for a smarter, faster, and more comprehensive lab partner, this is a significant step forward. Better diagnostics, broader access, and stronger patient outcomes at scale.

Read the full announcement: https://www.einpresswire.com/article/918976688/gopath-diagnostics-announces-strategic-national-agreement-with-capstone-health-alliance

The 86th American Diabetes Association Scientific Sessions start today!

Swing by booth 2220 to learn how DIABETESNOW tests for MODY, syndromic, neonatal, and mitochondrial causes of monogenic diabetes, along with pan-ancestry Type 1 and Type 2 PRS and GenProb-T1D.

As Bladder Cancer Awareness Month comes to a close, we want to take a moment to recognize the researchers, patients, and advocates working to change the future of this disease. This May, we are proud to join AACR in shining a light on bladder cancer and the ongoing progress being made. The work is not done, but every step forward matters.

Learn more from the American Association for Cancer Research (AACR):

May is Bladder Cancer Awareness Month More than 80,000 people living in the U.S. will be diagnosed with bladder cancer. Learn more about bladder cancer.